Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/RespireRx Pharmaceuticals Inc./ 10-K

Annual Report · 10-K

RespireRx Pharmaceuticals Inc.

Annual Report

Filed Apr 15, 2022Accepted Apr 15, 2022, 10:12 AM EDTCIK 849636Accession 0001493152-22-010053
View company →Permanent SEC source ↗
Share

Company context

Historical securities (2)
RSPIOTC · EQUITY · Historical · closed Nov 13, 2025RSPIDOTC · EQUITY · Historical · closed Feb 3, 2021

Recent company filings

  1. REVOKED filingNov 14, 2025
  2. Regulation FD DisclosureFeb 10, 2025
  3. 8-K filingSep 6, 2024
  4. 8-K filingAug 2, 2024
  5. 8-K filingJul 8, 2024

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗